All Stories

  1. An Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses

    Article • Journal of Virology, January 2020, ASM Journals

    PhD Giuseppe Andrea Sautto

  2. A Computationally Optimized Broadly Reactive Antigen Subtype–Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin

    Article • The Journal of Immunology, December 2019, The American Association of Immunologists

    PhD Giuseppe Andrea Sautto

  3. Pre-existing subtype immunodominance shapes memory B cell recall response to influenza vaccination

    Article • JCI Insight, December 2019, American Society for Clinical Investigation

    PhD Giuseppe Andrea Sautto

  4. Next Generation Vaccines for Infectious Diseases

    Article • Journal of Immunology Research, April 2019, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  5. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

    Article • Journal of Immunology Research, March 2019, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  6. Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens

    Article • ImmunoHorizons, August 2018, The American Association of Immunologists

    PhD Giuseppe Andrea Sautto

  7. Infection of Ferrets with Influenza Virus Elicits a Light Chain–Biased Antibody Response against Hemagglutinin

    Article • The Journal of Immunology, October 2017, The American Association of Immunologists

    PhD Giuseppe Andrea Sautto

  8. Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge

    Article • Antiviral Research, July 2017, Elsevier

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  9. A Biologically-validated HCV E1E2 Heterodimer Structural Model

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    PhD Giuseppe Andrea Sautto

  10. Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study

    Article • Autoimmunity Reviews, March 2017, Elsevier

    PhD Giuseppe Andrea Sautto

  11. New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases

    Article • Journal of Immunology Research, January 2017, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto

  12. Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?

    Article • Clinical Microbiology and Infection, August 2015, Elsevier

    PhD Giuseppe Andrea Sautto

  13. Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections

    Article • Future Microbiology, April 2015, Future Medicine

    PhD Giuseppe Andrea Sautto

  14. Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein

    Article • Gut, February 2015, BMJ

    PhD Giuseppe Andrea Sautto

  15. HCV E2 core structures and mAbs: something is still missing

    Article • Drug Discovery Today, December 2014, Elsevier

    PhD Giuseppe Andrea Sautto

  16. Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy

    Article • Antiviral Research, August 2014, Elsevier

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  17. Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  18. Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies

    Article • Clinical and Developmental Immunology, January 2013, Hindawi Publishing Corporation

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  19. Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclonal Antibodies and the Identification of T-Cell-Activating Peptides

    Article • Clinical and Developmental Immunology, January 2013, Hindawi Publishing Corporation

    PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  20. Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII)

    Article • Viruses, November 2012, MDPI AG

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  21. Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference

    Article • Antiviral Research, October 2012, Elsevier

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  22. Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?

    Article • Viruses, September 2012, MDPI AG

    Nicasio Mancini, PhD Giuseppe Andrea Sautto, Dr Elena Criscuolo

  23. HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role

    Article • Clinical and Developmental Immunology, January 2012, Hindawi Publishing Corporation

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  24. Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV)

    Article • Virology, March 2010, Elsevier

    Nicasio Mancini, PhD Giuseppe Andrea Sautto

  25. Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

    Article • PLoS ONE, December 2009, PLOS

    Nicasio Mancini, PhD Giuseppe Andrea Sautto